by Admin | Dec 30, 2019 | Portfolio News
BEIJING, China – 30 December 2019 – Clover Biopharmaceuticals, a global clinical-stage biotechnology company focused on developing novel and transformative biologic therapies, today announced that the first patient was dosed in a Phase III trial of SCB-808, a proposed...
by Admin | Dec 26, 2019 | Portfolio News
December 26, 2019 The Barricaid team is proud to be ranked among the top 20 private medtech companies to watch in 2020 by MDDI (Medical Device and Diagnostic Industry). To our mission, we stay committed to reducing needless suffering by ensuring Barricaid Annular...
by Admin | Dec 10, 2019 | Portfolio News
December 10, 2019 08:00 AM Eastern Standard Time CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc. today announced that it has completed the initial closing of a Series C financing of $85 million to support the commercial launch of the company’s...
by Admin | Oct 8, 2019 | Portfolio News
2019年10月8日，卢凯制药与ADARE制药共同对外宣布旗下消化科产品-乐托尔（灭活嗜酸乳杆菌LB）LACTEOL®，在中国获批，全国进驻中国市场。 根据此前宣布的战略合作协议，ADARE制药授予卢凯在中国的经营和分销权，并将从其位于法国乌当的生产中心直接进口。卢凯将在中国独家销售和分销乐托尔。 卢凯制药已经凭借自己的销售队伍和分销网络在中国消化科处方市场上建立了稳固的地位，而乐托尔将为卢凯已然强大的消化科产品组合增添新的力量。 关于乐托尔...
by Admin | Sep 20, 2019 | Portfolio News
HONG KONG, Sept. 20, 2019 /PRNewswire/ — Delos Capital today announces that it has launched Curamir Therapeutics Inc., a Woburn, MA-based biotechnology company pioneering micro RNA (miRNA) based cancer therapeutics, with a $10 million Series A financing. Curamir...
by Admin | Jul 29, 2019 | Portfolio News
July 29, 2019 Investor Announcements Tags Date of occurrence of the event: Jul 29, 2019 Counterparty to the contract or commitment: Tasly Biopharmaceuticals Co. Ltd Relationship to the Company: None Starting and ending dates (or rescission date) of the contract or...
